NASDAQ:DRAD - Digirad Stock Price, News & Analysis

$4.84
-0.17 (-3.39 %)
(As of 09/17/2019 04:00 PM ET)
Today's Range
$4.65
Now: $4.84
$5.19
50-Day Range
$4.41
MA: $4.80
$5.65
52-Week Range
$4.20
Now: $4.84
$15.90
Volume36,500 shs
Average Volume23,916 shs
Market Capitalization$9.89 million
P/E RatioN/A
Dividend YieldN/A
Beta2.29
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DRAD
CUSIPN/A
Phone858-726-1600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$104.18 million
Cash Flow$2.75 per share
Book Value$12.75 per share

Profitability

Net Income$740,000.00

Miscellaneous

Employees452
Market Cap$9.89 million
Next Earnings Date11/1/2019 (Estimated)
OptionableOptionable

Receive DRAD News and Ratings via Email

Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter.


Digirad (NASDAQ:DRAD) Frequently Asked Questions

What is Digirad's stock symbol?

Digirad trades on the NASDAQ under the ticker symbol "DRAD."

When did Digirad's stock split? How did Digirad's stock split work?

Digirad's stock reverse split on the morning of Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of Digirad stock prior to the reverse split would have 10 shares after the split.

How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) announced its earnings results on Tuesday, August, 6th. The medical equipment provider reported $0.04 EPS for the quarter. The medical equipment provider earned $25.80 million during the quarter. Digirad had a negative return on equity of 10.97% and a negative net margin of 5.81%. View Digirad's Earnings History.

When is Digirad's next earnings date?

Digirad is scheduled to release their next quarterly earnings announcement on Friday, November 1st 2019. View Earnings Estimates for Digirad.

What guidance has Digirad issued on next quarter's earnings?

Digirad issued an update on its FY 2020 earnings guidance on Monday, September, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $130-150 million.

Has Digirad been receiving favorable news coverage?

Media stories about DRAD stock have been trending negative this week, according to InfoTrie. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Digirad earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Digirad.

Are investors shorting Digirad?

Digirad saw a increase in short interest during the month of August. As of August 31st, there was short interest totalling 29,900 shares, an increase of 27.8% from the July 31st total of 23,400 shares. Based on an average daily trading volume, of 11,400 shares, the days-to-cover ratio is currently 2.6 days. Currently, 1.6% of the company's shares are sold short. View Digirad's Current Options Chain.

Who are some of Digirad's key competitors?

What other stocks do shareholders of Digirad own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Exelixis (EXEL), Novavax (NVAX), Prospect Capital (PSEC), AT&T (T), Cronos Group (CRON), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Enterprise Products Partners (EPD), General Electric (GE) and AcelRx Pharmaceuticals (ACRX).

Who are Digirad's key executives?

Digirad's management team includes the folowing people:
  • Mr. Matthew Gabel Molchan, Pres, CEO & Director (Age 52)
  • Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 57)
  • Mr. David James Noble, COO & Interim CFO (Age 48)
  • Mr. Bob Halbert, Sr. Director of Human Resource

Who are Digirad's major shareholders?

Digirad's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (4.60%), Vanguard Group Inc. (4.06%) and Ancora Advisors LLC (3.99%). Company insiders that own Digirad stock include Cannell Capital Llc, David J Noble, David James Noble, Jeffrey E Eberwein, Matthew G Molchan and Virgil Lott. View Institutional Ownership Trends for Digirad.

Which major investors are selling Digirad stock?

DRAD stock was sold by a variety of institutional investors in the last quarter, including Ancora Advisors LLC, Renaissance Technologies LLC and Vanguard Group Inc.. View Insider Buying and Selling for Digirad.

How do I buy shares of Digirad?

Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Digirad's stock price today?

One share of DRAD stock can currently be purchased for approximately $4.84.

How big of a company is Digirad?

Digirad has a market capitalization of $9.89 million and generates $104.18 million in revenue each year. Digirad employs 452 workers across the globe.View Additional Information About Digirad.

What is Digirad's official website?

The official website for Digirad is http://www.digirad.com/.

How can I contact Digirad?

Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at [email protected]


MarketBeat Community Rating for Digirad (NASDAQ DRAD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  288 (Vote Outperform)
Underperform Votes:  222 (Vote Underperform)
Total Votes:  510
MarketBeat's community ratings are surveys of what our community members think about Digirad and other stocks. Vote "Outperform" if you believe DRAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DRAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel